InterventionsReview

Beyond Glycemic Control: Cardiovascular Benefits of GLP-1 Receptor Agonists in Type 2 Diabetes

AHA Scientific Sessions 2025 Abstract

The paper

Shahzeb Saeed, Ahmad Ramy Elashery, Vikash Kumar Karmani, Nisma Faridi

Charleston Area Medical Center · army medical college

AHA Scientific Sessions 2025 Abstract · 3 Nov 2025

Presented at AHA Scientific Sessions 2025 · Abstract 4364905

doi.org/10.1161/circ.152.suppl_3.4364905

GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
Lancet · 4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
Semaglutide improved heart artery function in pigs
Research Square · 8 Oct 2026